Form 4: Pulmonx Corp Director Mead Dana G Jr. Reports Acquisition and Disposal of Shares

Director Mead Dana G Jr. reports acquiring 15,216 shares of Pulmonx Corp through a restricted stock unit grant and disposing of 4,076 shares via a liquidation distribution.

Summary

• On June 3, 2024, Director Mead Dana G Jr. acquired 15,216 shares of Pulmonx Corp through a restricted stock unit (RSU) grant.
• The RSU grant vests on the earlier of June 3, 2025 (or the next business day if that date is not a business day) or the date of the next annual stockholder meeting.
• On the same day, Mead disposed of 4,076 shares as a liquidation distribution from KPCB XIII Associates, LLC.
• Following these transactions, Mead directly owns 62,561 shares of common stock.
• Mead also indirectly owns shares through The Mead Family Trust.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting transactions. The RSU grant is mildly positive, while the share disposal is mildly negative, resulting in a neutral overall sentiment.

Positives

• The RSU grant to a director could be seen as a positive sign, aligning the director's interests with those of the shareholders.

Negatives

• The disposal of 4,076 shares, even through a liquidation distribution, could be perceived negatively by some investors.

Risks

• The vesting of the RSU grant is contingent on future events, including the director's continued service and the timing of the annual stockholder meeting.
• Liquidation distributions can sometimes indicate broader changes within the investment firm making the distribution.

Future Outlook

The document does not contain specific forward-looking statements about Pulmonx Corp's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of shares through RSU grants is a common practice to incentivize and retain key personnel.

Comparison to Industry Standards

• RSU grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.
• Companies like Medtronic and Boston Scientific also utilize RSU grants as part of their executive compensation packages.
• Liquidation distributions are specific to the investment firms involved and don't necessarily reflect the performance of Pulmonx Corp.

Stakeholder Impact

• Shareholders may be interested in the director's transactions as an indicator of confidence in the company.
• Employees may view the RSU grant as a positive sign of the company's commitment to its leadership.

Next Steps

• Monitor future Form 4 filings to track insider transactions.
• Observe the vesting of the RSU grant and any subsequent share sales by the director.

Key Dates